Tagraxofusp for treating blastic plasmacytoid dendritic cell neoplasm (terminated appraisal)
Technology appraisal
Reference number: TA782
Published:
Please note that following on from a request received from the company, the timelines for this appraisal have been revised and the appraisal is now anticipated to restart during February 2022.